PET-CT Scanner Device Market Trends, and Growth Analysis 2024-2032

Global PET-CT Scanner Device Market Statistics: USD 3.1 Billion Value by 2032

PET-CT Scanner Device Industry

Summary:

• The global PET-CT scanner device market size reached USD 2.2 Billion in 2023.
• The market is expected to reach USD 3.1 Billion by 2032, exhibiting a growth rate (CAGR) of 3.62% during 2024-2032.
• North America leads the market, accounting for the largest PET-CT scanner device market share.
• Stationary scanners hold the majority of the market share in the type segment due to their cost-effectiveness and reliability.
• Medium slice scanner (64 slices) exhibits a clear dominance in the PET-CT scanner device industry.
• Fluorodeoxyglucose (FDG) remains a dominant segment in the market owing to its higher availability, sensitivity, reliability, and well-established production methods.
• Hospitals represent the leading service provider segment.
• Oncology accounts for the majority of the market share.
• The rising prevalence of chronic diseases is a primary driver of the PET-CT scanner device market.
• Technological Advancements and improving reimbursement policies are reshaping the PET-CT scanner device market.

Industry Trends and Drivers:

• Rising prevalence of chronic diseases:

As chronic conditions are becoming more prevalent worldwide, there is an increase in the demand for advanced diagnostic tools that can provide early detection, accurate staging, and effective treatment monitoring, which is fueling the market growth. PET-CT scanners, which combine positron emission tomography (PET) and computed tomography (CT), provide both functional and structural imaging in one scan, allowing for a more comprehensive view of disease progression, and enabling physicians to detect abnormalities. PET-CT scanners are crucial for diagnosing neurological disorders, staging cancers, evaluating treatment responses, and detecting recurrent tumors. PET-CT can be used to assess heart conditions by identifying areas of reduced blood flow and metabolic activity, aiding in the evaluation of heart disease severity and the effectiveness of interventions.

• Technological Advancements:

Innovations in technology are improving the functionality and efficiency of diagnostic imaging, which are impelling the market growth. Advanced radiotracers and improved detectors enable PET-CT scanners to provide more precise molecular-level imaging and better identification of metabolic changes in tissues. Faster scan times due to advancements in detector technology and computer processing are reducing patient wait times and improving patient throughput in busy healthcare settings. Furthermore, innovations in software, such as the development of more powerful image reconstruction algorithms, enable better image quality with lower radiation doses, enhancing both patient safety and the overall efficiency of PET-CT systems.

• Improving reimbursement policies:

Reimbursement policies from public and private insurers are essential for covering the high costs associated with PET-CT scans, including the purchase of the devices, maintenance, and operational expenses. As reimbursement rates for PET-CT scans are improving, hospitals and diagnostic centers are more likely to invest in and adopt these technologies, recognizing the potential for long-term economic benefits and the ability to offer high-quality diagnostic services. In many regions like the US and Europe, insurance companies and government health programs, such as Medicare and Medicaid are expanding coverage for PET-CT scans. With the cost burden becoming less prohibitive, the adoption of PET-CT scanners, especially in smaller and community-based hospitals is increasing, thereby propelling the market growth.

Request for a sample copy of this report: https://www.imarcgroup.com/pet-ct-scanner-device-market/requestsample

PET-CT Scanner Device Market Report Segmentation:

Breakup By Type:

• Stationary Scanners
• Portable Scanners/Mobile Scanners

Stationary scanners represent the largest segment because they provide reliability and advanced diagnostic capabilities required in high-volume medical facilities.

Breakup By Slice Count:

• Low Slice Scanner (<64 Slices)
• Medium Slice Scanner (64 Slices)
• High Slice Scanner (>64 Slices)

Medium slice scanner (64 slices) accounts for the majority of the market share due to its balance between cost-effectiveness and advanced imaging capabilities suitable for diverse diagnostic needs.

Breakup By Isotope and Detector Type:

• Flurodeoxyglucose (FDG)
• 62Cu ATSM
• 18 F Sodium Fluoride
• FMISO
• Gallium
• Thallium
• Others

Fluorodeoxyglucose (FDG) exhibits a clear dominance in the market, which can be attributed to its increasing usage for detecting chronic diseases and assessing metabolic activity.

Breakup By Service Provider:

• Hospitals
• Diagnostic Centers
• Research Institutes

Hospitals hold the biggest market share on account of being the primary facilities that offer comprehensive diagnostic imaging services, including PET-CT scans.

Breakup By Application:

• Oncology
• Neurology
• Cardiology
• Others

Oncology dominates the market, as PET-CT scanners are crucial for cancer detection, staging, and treatment monitoring.

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Asia-Pacific enjoys the leading position in the market owing to the rising prevalence of chronic diseases, increasing healthcare investments, and expanding diagnostic infrastructure.

Top PET-CT Scanner Device Market Leaders:

The PET-CT scanner device market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

• Bruker Corporation
• Canon Medical Systems Usa Inc.
• General Electric Company
• Hitachi Ltd.
• Koninklijke Philips N.V.
• Mediso Ltd.
• Neusoft Corporation
• Positron Corporation
• Shimadzu Corporation
• Siemens Healthcare GmbH (Siemens AG)
• Sofie Biosciences Inc.
• United Imaging Healthcare Co. Ltd.
• Yangzhou Kindsway Biotech Co. Ltd.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163